Literature DB >> 18958254

Primary PCI: false positives versus false negatives.

W J van der Giessen1.   

Abstract

Year:  2008        PMID： 18958254      PMCID： PMC2570762          DOI： 10.1007/bf03086172

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


× No keyword cloud information.
  5 in total

1.  Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy.

Authors:  Menko-Jan de Boer; Jan-Paul Ottervanger; Arnoud W J van 't Hof; Jan C A Hoorntje; Harry Suryapranata; Felix Zijlstra
Journal:  J Am Coll Cardiol       Date:  2002-06-05       Impact factor: 24.094

2.  Conditions mimicking acute ST-segment elevation myocardial infarction in patients referred for primary percutaneous coronary intervention.

Authors:  Y L Gu; T Svilaas; I C C van der Horst; F Zijlstra
Journal:  Neth Heart J       Date:  2008-10       Impact factor: 2.380

3.  "False-positive" cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarction.

Authors:  David M Larson; Katie M Menssen; Scott W Sharkey; Sue Duval; Robert S Schwartz; James Harris; Jeffrey T Meland; Barbara T Unger; Timothy D Henry
Journal:  JAMA       Date:  2007-12-19       Impact factor: 56.272

Review 4.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

5.  Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.

Authors:  Sigmund Silber; Per Albertsson; Francisco F Avilés; Paolo G Camici; Antonio Colombo; Christian Hamm; Erik Jørgensen; Jean Marco; Jan-Erik Nordrehaug; Witold Ruzyllo; Philip Urban; Gregg W Stone; William Wijns
Journal:  Eur Heart J       Date:  2005-03-15       Impact factor: 29.983
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.